Skip to main content

Novo Nordisk A/S

corporate_fare Company Profile

Novo Nordisk A/S

NONOF·OTC·Life Sciences

Novo Nordisk A/S researches, develops, manufactures, and distributes pharmaceutical products. The company operates through two primary segments: Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes Care segment focuses on products for diabetes, obesity, cardiovascular conditions, and other emerging therapy areas. The Rare Disease segment provides products for rare blood disorders, rare endocrine disorders, and hormone replacement therapy. Novo Nordisk A/S also offers medical devices such as NovoPen 6 and NovoPen Echo Plus, which are smart insulin pens, and Dose Check, an insulin dose guidance application. Additionally, it provides growth hormone pens and injection needles. The company's product portfolio includes Wegovy pill, an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. Novo Nordisk A/S has a global presence, operating in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Novo Nordisk A/S (OTC:NONOF) is a publicly traded company in the Life Sciences sector.

Short Interest & Short Volume

139.32 days to cover

FINRA reported short interest of 11,654,884 shares in NONOF as of the October 30, 2026 settlement, a 2.2% increase from the prior period — about 139.3 days to cover at its recent average daily volume. On November 19, 2026, 29.8% of NONOF volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)11,654,884 shares as of October 30, 2026
Change vs prior period▲ 2.2%
Days to cover139.32 at avg daily volume of 83,653
Daily short volume (FINRA facilities)29.8% of 18,224 shares on November 19, 2026
5-day average short volume49.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

show_chartPrice Chart

Loading chart...

feed NONOF - Latest Insights

Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets